Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
Journal of Clinical Medicine · 28.11.2024 · 13 (23) · 7243
DOI: 10.3390/jcm13237243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.11.2024. Verfasst von Hyemi Eo und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Biotechnology, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of Korea. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by both motor symptoms and non-motor features. A hallmark of PD is the misfolding and accumulation of alpha-synuclein (α-syn), which triggers neuroinflammation and drives neurodegeneration. Microglia, brain cells that play a central role in neuroinflammatory responses and help clear various unnecessary molecules within the brain, thus maintaining the brain’s internal environment, respond to α-syn through mechanisms involving inflammation, propagation, and clearance. This review delves into the complex interplay between α-syn and microglia, elucidating how these interactions drive PD pathogenesis. Furthermore, we discuss emerging therapeutic strategies targeting the α-syn–microglia axis, with a focus on modulating microglial functions to mitigate neuroinflammation, enhance clearance, and prevent α-syn propagation, emphasizing their potential to slow PD progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Science and Biotechnology, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of Korea.
- Department of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea.
- Brain Science and Engineering Institute, Kyungpook National University, Daegu 41404, Republic of Korea.
ORCID-Profile: Hyemi Eo, Un Ju Jung, Sang Ryong Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Eo, H., Kim, S., Jung, U. J., & Kim, S. R. (2024). Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects. Journal of Clinical Medicine, 13(23), 7243. https://doi.org/10.3390/jcm13237243
Vancouver
Eo H, Kim S, Jung UJ, Kim SR. Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects. Journal of Clinical Medicine. 2024;13(23):7243. doi:10.3390/jcm13237243
BibTeX
@article{Eo2024,
author = {Eo, Hyemi and Kim, Sehwan and Jung, Un Ju and Kim, Sang Ryong},
title = {Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {23},
pages = {7243},
doi = {10.3390/jcm13237243}
}
EUVIMED